SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473,829 | -12.2% | 20,508 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $539,793 | +3.0% | 20,582 | +1.1% | 0.00% | 0.0% |
Q1 2023 | $523,982 | -34.8% | 20,356 | -33.6% | 0.00% | 0.0% |
Q4 2022 | $804,114 | +38.6% | 30,643 | +50.5% | 0.00% | -33.3% |
Q3 2022 | $580,000 | -9.1% | 20,356 | -21.4% | 0.00% | 0.0% |
Q2 2022 | $638,000 | +150.2% | 25,882 | +471.9% | 0.00% | +200.0% |
Q1 2022 | $255,000 | +8.1% | 4,526 | +19.0% | 0.00% | 0.0% |
Q4 2021 | $236,000 | +3.5% | 3,803 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $228,000 | -23.0% | 3,596 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $296,000 | +12.1% | 3,596 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $264,000 | -45.1% | 3,596 | -45.8% | 0.00% | -50.0% |
Q4 2020 | $481,000 | +52.7% | 6,630 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $315,000 | +45.8% | 6,613 | +28.4% | 0.00% | +100.0% |
Q2 2020 | $216,000 | – | 5,149 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |